New Jersey imposes strict limits on pharma payments, gifts to clinicians

New Jersey’s Office of the Attorney General finalized rules limiting drug companies’ payments and gifts to healthcare providers, reports Policy and Medicine.

Advertisement

Here are three things to know.

1. As of Jan. 15, all contracts and payments between New Jersey clinicians and drugmakers are subject to a $10,000 annual cap. The rule includes payments for consulting and speaking engagements, but exempts research and education-related payments.

  1. Drug companies must also follow a $15 cap on meals with clinicians.
  1. Clinicians are forbidden from accepting other gifts from drugmakers, such as tickets to a sporting event or gift certificates.

“The rules in this chapter regulate the receipt and acceptance by prescribers of anything of value from pharmaceutical manufacturers to ensure that such relationships do not interfere with prescribers’ independent professional judgment,” the official rule document states.

To view a complete outline of the rules, click here.

More articles on supply chain:
Celgene to acquire Juno Therapeutics for $9B, betting on a future for CAR-T therapies
Kick-start your supply chain in 2018: 3 New Year’s Resolutions
Recognize 5 types of supply chain leaders in your hospital

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.